Verax Biomedical gets FDA OK for platelet PGD test

The FDA has granted Verax Biomedical clearance to label and market its Platelet PGD test as a safety measure for blood platelet transfusions. The $30 assay, which is being marketed by Fenwal globally, takes less than 30 minutes to spot bacterial contamination in platelets prior to transfusion.

View Full Article in:

Mass High Tech (Boston) · Telegram & Gazette (Worcester, Mass.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX